These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9453576

  • 1. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.
    Brouillet E, Guyot MC, Mittoux V, Altairac S, Condé F, Palfi S, Hantraye P.
    J Neurochem; 1998 Feb; 70(2):794-805. PubMed ID: 9453576
    [Abstract] [Full Text] [Related]

  • 2. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S, Bizat N, Altairac S, Ménétrat H, Mittoux V, Condé F, Hantraye P, Brouillet E.
    Neuroscience; 2000 Feb; 97(3):521-30. PubMed ID: 10828534
    [Abstract] [Full Text] [Related]

  • 3. 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions.
    Mirandola SR, Melo DR, Saito A, Castilho RF.
    J Neurosci Res; 2010 Feb 15; 88(3):630-9. PubMed ID: 19795369
    [Abstract] [Full Text] [Related]

  • 4. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.
    Alexi T, Hughes PE, Knüsel B, Tobin AJ.
    Exp Neurol; 1998 Sep 15; 153(1):74-93. PubMed ID: 9743569
    [Abstract] [Full Text] [Related]

  • 5. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.
    Guyot MC, Palfi S, Stutzmann JM, Mazière M, Hantraye P, Brouillet E.
    Neuroscience; 1997 Nov 15; 81(1):141-9. PubMed ID: 9300407
    [Abstract] [Full Text] [Related]

  • 6. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC, Hantraye P, Dolan R, Palfi S, Maziére M, Brouillet E.
    Neuroscience; 1997 Jul 15; 79(1):45-56. PubMed ID: 9178864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
    Blum D, Gall D, Cuvelier L, Schiffmann SN.
    Neuroreport; 2001 Jun 13; 12(8):1769-72. PubMed ID: 11409756
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms.
    Galas MC, Bizat N, Cuvelier L, Bantubungi K, Brouillet E, Schiffmann SN, Blum D.
    Neurobiol Dis; 2004 Feb 13; 15(1):152-9. PubMed ID: 14751780
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
    Lee ST, Chu K, Park JE, Hong NH, Im WS, Kang L, Han Z, Jung KH, Kim MW, Kim M.
    J Neurochem; 2008 Mar 13; 104(5):1190-200. PubMed ID: 17976163
    [Abstract] [Full Text] [Related]

  • 16. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.
    Maragos WF, Tillman PA, Chesnut MD, Jakel RJ.
    Brain Res; 1999 Jul 10; 834(1-2):168-72. PubMed ID: 10407109
    [Abstract] [Full Text] [Related]

  • 17. Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid.
    Rosenstock TR, Abílio VC, Frussa-Filho R, Kiyomoto BH, Smaili SS.
    Pharmacol Biochem Behav; 2009 Jan 10; 91(3):327-32. PubMed ID: 18765248
    [Abstract] [Full Text] [Related]

  • 18. N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity.
    Nasr P, Carbery T, Geddes JW.
    Neurochem Res; 2009 Mar 10; 34(3):490-8. PubMed ID: 18688711
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.